Recent Updates
Recently added Catalysts
VNRX Positive Sentiment

Early Detection with Canine Cancer Screening

Key Takeaway: The webinar focuses on the challenges in diagnosing canine cancer and presents clinical data from studies on the Nu.Q® Vet Cancer Test. Dr. Sue Ettinger, a prominent veterinary oncologist, leads the discussion, which includes sample processing, result interpretation, and case studies. The event aims to enhance understanding of this innovative cancer screening method.
Price reaction · baseline $14.002 (2025-07-17T15:18:00.000Z) · hit during market hours · clean, no other VNRX news in the window
day 0 close · peak
-3.4%

Market Sentiment Analysis

POSITIVE FACTORS

  • Webinar addresses unmet needs in canine cancer diagnosis.
  • Clinical data presented from studies of the Nu.Q® Vet Cancer Test.
  • Case studies illustrate practical applications of the test.

Full Press Release Details

Early Detection with Canine Cancer Screening

This webinar covers the challenges and unmet needs in the diagnosis of canine cancer, shares clinical data from studies of the Nu.Q ® Vet Cancer Test, how to process the sample and interpret results, and provides case study examples to illustrate how the test may / may not be used. The presenter is a leading light in the veterinary oncology field, Dr Sue Ettinger aka, Dr Sue Cancer Vet.
RACE approved # 20-1297169, available in 20+ languages
Watch Here

Related Articles

• Press Releases Volition Announces Submission of Manuscript for Nu.Q® Vet Cancer Test in Cats. The publication of this study in a peer reviewed journal is expected subsequently to unlock a $5 million contractual milestone payment
• Press Releases Volition Announces First Ever Automated Nu.Q® Vet Cancer Test with Fujifilm Vet Systems

Volition Announces Submission of Manuscript for Nu.Q® Vet Cancer Test in Cats. The publication of this study in a peer reviewed journal is expected subsequently to unlock a $5 million contractual milestone payment

Volition Announces First Ever Automated Nu.Q® Vet Cancer Test with Fujifilm Vet Systems

• Share
• Tweet
• Share on Facebook
• Share

Subscribe for Volition product updates .

Or, click here for Investor Updates and press releases .

" * " indicates required fields

Frequently Asked Questions

What is the focus of the canine cancer screening webinar?

The webinar addresses challenges in diagnosing canine cancer and presents clinical data on the Nu.Q® Vet Cancer Test.

Who is presenting the webinar on canine cancer screening?

Dr. Sue Ettinger, a leading veterinary oncologist, is the presenter.

What will be discussed regarding the Nu.Q® Vet Cancer Test?

The webinar will cover sample processing, result interpretation, and case study examples.

Is the webinar accessible in multiple languages?

Yes, the webinar is available in over 20 languages.

Last updated: Jul 17, 2025